Future Therapies of Wet Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population, and the prevalence of the disease increases exponentially with every decade after the age of 50 years. While VEGF inhibitors are promising drugs for treating patients with ocular neovascularization, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Makoto, Jin, Daisuke, Sawada, Yu, Abe, Sanae, Yoshitomi, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354726/
https://www.ncbi.nlm.nih.gov/pubmed/25802751
http://dx.doi.org/10.1155/2015/138070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354726/
https://www.ncbi.nlm.nih.gov/pubmed/25802751
http://dx.doi.org/10.1155/2015/138070

Ejemplares similares